Evommune (EVMN) Enterprise Value (2024 - 2026)
Evommune (EVMN) reported Enterprise Value of -$211.5 million for Q1 2026, down 3607.29% year-over-year from $6.0 million in Q1 2025, and down 41.73% quarter-over-quarter from -$149.2 million in Q4 2025.
Evommune (EVMN) Enterprise Value (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Enterprise Value data on file, last reported at -$211.5 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$211.5 million, down 3607.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$211.5 million (down 3607.29% YoY), and the FY2025 annual result was -$149.2 million, down 107.11% from the prior year.
- Enterprise Value retreated to -$211.5 million in Q1 2026 per EVMN's latest filing, from -$149.2 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$5.7 million in Q1 2025 and troughed at -$211.5 million in Q1 2026.
- A 3-year average of -$88.8 million and a median of -$74.1 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2025 and 2026: Enterprise Value sank 107.11% in 2025, then plunged 3607.29% in 2026.
- A 3-year view of Enterprise Value shows it stood at -$72.0 million in 2024, then slumped by 107.11% to -$149.2 million in 2025, then sank by 41.73% to -$211.5 million in 2026.
- Business Quant data shows EVMN's Enterprise Value at -$211.5 million in Q1 2026, -$149.2 million in Q4 2025, and -$76.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Evommune | 695.29 Mn | 483.82 Mn | - | -211.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -211.46 Mn |
| Dec 31, 2025 | -149.20 Mn |
| Sep 30, 2025 | -76.06 Mn |
| Mar 31, 2025 | -5.70 Mn |
| Dec 31, 2024 | -72.04 Mn |
| Sep 30, 2024 | -18.15 Mn |